| Literature DB >> 35270748 |
Lorenzo Palamenghi1,2,3, Fabiola Giudici4, Guendalina Graffigna1,3, Daniele Generali5,6,7.
Abstract
COVID-19 exerted a strong impact on the Italian healthcare systems, which in turn resulted in a reduction in the citizens' trust towards healthcare authorities. Moreover, the focused attention on the typical COVID-19 symptoms (fever, cough) has also impacted the social representation of health priorities, potentially reducing the perceived importance and severity of other symptoms. This study aimed to determine the association of general-practitioner (GP) contact with various symptoms during the COVID-19 pandemic in Cremona, an Italian city at the very epicentre of the pandemic. Between April and June 2020, an anonymous survey was completed by 2161 respondents. Logistic-regression analyses were used to examine the associations of GP contact with sociodemographic characteristics and the presence of symptoms. Of the 2161 respondents (43.5% female, 75.0% aged less than 55 years), 959 (44.4%) reported experiencing various symptoms and 33.3% contacted a GP. GP contact was significantly associated with poor appetite (OR, 2.42; 95% CI 1.63 to 3.62; p < 0.001), taste dysfunctions (OR 1.67; 95% CI 1.20 to 2.34; p < 0.001) and sleepiness during the day (OR 4.15; 95% CI 2.13 to 8.09; p = 0.002). None of the gastrointestinal symptoms resulted in significantly increasing the likelihood of contacting a GP. This study offers a unique observation of citizens' attitudes and behaviours in early symptom communication/detection during the initial peak of the Italian COVID-19 pandemic.Entities:
Keywords: COVID-19; general practitioner; health engagement; public health; symptoms
Mesh:
Year: 2022 PMID: 35270748 PMCID: PMC8910395 DOI: 10.3390/ijerph19053058
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sample characteristics.
| Variables | Cohort: |
|---|---|
|
| |
| Blood donors | 1569 (72.61%) |
| Healthcare Professionals | 407 (18.83%) |
| Volunteers | 185 (8.56%) |
|
| |
| 18–25 | 153 (7.08%) |
| 26–45 | 831 (38.45%) |
| 46–55 | 637 (29.48%) |
| 56–65 | 430 (19.90%) |
| 66–75 | 102 (4.72%) |
| 76–80 | 6 (0.28%) |
| 81–85 | 2 (0.09%) |
|
| |
| Female | 940 (43.50%) |
| Male | 1220 (56.5%) |
| No answer | 1 (0.05%) |
|
| |
| Past Smoker | 410 (18.97%) |
| Current Smoker | 334 (15.46%) |
| Never Smoker | 1417 (65.57%) |
|
| |
| Underweight | 50 (2.31%) |
| Normal weight | 1229 (56.87%) |
| Overweight | 678 (31.37%) |
| Obesity | 191 (8.84%) |
| Unknown | 13 (0.60%) |
|
| |
| Employed | 1802 (83.39%) |
| Retired | 196 (9.07%) |
| Student | 92 (4.26%) |
| Unemployed | 62 (2.87%) |
| Unknown | 9 (0.42%) |
|
| |
| Alone | 357 (16.52%) |
| Not Alone | 1718 (79.50%) |
| Unknown | 86 (3.98%) |
|
| |
| None | 1613 (74.64%) |
| 1 | 429 (19.85%) |
| 2 | 102 (4.72%) |
| >2 | 17 (0.79%) |
|
| |
| Anti-flu in last autumn | 412 (19.07%) |
| Pneumococcal in the last 12 months | 53 (2.45%) |
| Other vaccinations in the past 12 months | 254 (11.75%) |
|
| |
| Diarrhoea | 307 (14.2%) |
| Nausea/vomiting | 152 (7.0%) |
| Poor appetite | 236 (10.9%) |
| Smell dysfunction | 279 (12.9%) |
| Taste dysfunction | 280 (13.0%) |
| Dizziness | 163 (7.5%) |
| Headache | 641(29.7%) |
| Sleepiness during the day | 369 (17.1%) |
| Confusion | 95 (4.4%) |
| Involuntary tremors | 80 (3.7%) |
| Tingling in the limbs/face | 163 (7.5%) |
| At least one of previous symptoms | 959 (44.4%) |
Results from logistic regressions (univariate and multivariate) for the cohort of 959 interviewed participants reporting at least one symptom.
| Univariate Analysis | Multivariate Analysis 1 | |||
|---|---|---|---|---|
| Variable | OR (95% CI) | OR (95% CI) | ||
| Age | ||||
| <55 | 1.00 (Reference) | |||
| >55 | 0.95 (0.67–1.35) | 0.785 | ||
|
| ||||
| Female | 1.00 (Reference) | |||
| Male | 0.96 (0.73–1.25) | 0.749 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 0.99 (0.69–1.43) | 0.975 | ||
|
| ||||
| Smoker | 1.00 (Reference) | |||
| Non-smoker | 1.47 (0.99–2.18) | 0.055 | ||
| Former smoker | 1.26 (0.78–2.04) | 0.338 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 0.90 (0.66–1.23) | 0.506 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 1.16 (0.86–1.56) | 0.322 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 1.92 (1.44–2.54) | <0.001 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 2.91 (2.04–4.14) | <0.001 | ||
|
| ||||
| No | 1.00 (Reference) | 1.00 (Reference) | ||
| Yes | 6.02 (4.38–8.28) | <0.001 | 2.42 (1.63–3.62) | <0.001 |
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 6.26 (4.62–8.49) | <0.001 | ||
|
| ||||
| No | 1.00 (Reference) | 1.00 (Reference) | ||
| Yes | 7.17 (5.27–9.75) | <0.001 | 1.67 (1.20–2.34) | <0.001 |
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 1.76 (1.25–2.48) | 0.013 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 1.00 (Reference) | 0.447 | ||
|
| ||||
| No | 1.00 (Reference) | 1.00 (Reference) | ||
| Yes | 2.12 (1.61–2.79) | <0.001 | 4.15 (2.13–8.09) | 0.002 |
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 2.34 (1.53–3.59) | <0.001 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 3.18 (1.99–5.07) | <0.001 | ||
|
| ||||
| No | 1.00 (Reference) | |||
| Yes | 1.25 (0.88–1.77) | 0.217 | ||
|
| ||||
| 1 | 1.00 (Reference) | |||
| 2 | 2.40 (1.48–3.88) | <0.001 | ||
| 3 | 6.06 (3.75–9.79) | <0.001 | ||
| ≥4 | 6.06 (3.75–9.79) | <0.001 | ||
OR: odds ratio; CI: confidence interval; Odds ratio represents the probability of contacting a GP over probability of not contacting a GP. 1 In the table, only the statistically significant variables implemented in the multivariate model are reported. 2 Not evaluated in multivariate analyses due to multicollinearity issues.